C‐MET is known to be overexpressed in HCC, and the HGF/C‐MET axis is involved in cell proliferation, angiogenesis, and apoptosis by activating multiple downstream signaling pathways, such as STAT3 and MAPK.13, 22, 23. The gene discussed is MET; the disease is hepatocellular carcinoma.